Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The aim of this study is to assess PE-A5% as a treatment for patients with ACLF in a pivotal study Methods: A phase 3, multicenter, randomized (1:1), controlled, parallel-group, open-label study (APACHE) compares standard medical treatment (SMT) + PE-A5% (treatment arm) to SMT alone (control arm)
Each "unit" on the syringe is 0.01 mL
Lactate, histone lactylation and cancer hallmarks
in Biomedical Science, conducting her graduate research at St
US$ 20.36
US$ 27.83
US$ 26.10
US$ 29.23
US$ 25.75
US$ 21.45
US$ 26.07
US$ 23.97
US$ 26.23
